MCPs produced by enzymatic degradation of pectasol, induced apoptosis in prostate cancer cells and increased the doubling time of prostate-specific antigen (PSA) in patients undergoing various treatments used to treat prostate cancer. Here, KLK3 is linked to prostate carcinoma.